Targeting the androgen receptor signalling axis in castration-resistant prostate cancer (CRPC).
published in: BJU International
date of publication: 2012-09-18
main subject: enzalutamide, prostate cancer
Cites articles 51
- 2005-05-01
Date
Title
Article - wd:Q38044064